Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.44 |
| ▸ | NAAA | Q02083 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.37 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.37 |
| ▸ | DRD1 | P21728 | 1/20 | 0.37 |
| ▸ | DRD4 | P21917 | 1/20 | 0.37 |
| ▸ | DRD5 | P21918 | 1/20 | 0.37 |
| ▸ | HRH2 | P25021 | 1/20 | 0.37 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.37 |
| ▸ | HTR2A | P28223 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2050725 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL541628 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL515189 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL2048861 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL542243 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL514845 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL3493992 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL28883791 | 1.00 | SLC18A3 (0.44) | SLC18A3NAAANPC1LMNATP53 | |
| SCHEMBL27967862 | 0.92 | NAAA (0.46) | NAAANPC1LMNATP53HPGD | |
| SCHEMBL27967864 | 0.92 | NAAA (0.46) | NAAANPC1LMNATP53HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2414339-B1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-[5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LTD (IN) | 2013-01-16 | — | — | EP | claimed |
| EP-2414339-A1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-Ý5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL¨-1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | Lupin Ltd. (IN) | 2012-02-08 | — | — | EP | claimed |
| US-20120028340-A1 | KINETIC RESOLUTION OF (4S) -- 4- PHENYL -- 3- [(5RS)-5-(4-FLUROPHENYL)-5- HYDROXYPENTANOYL] --1,3-OXAZOLIDIN-2-ONE TO THE (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LIMITED (IN) | 2012-02-02 | — | — | US | claimed |
| WO-2010113184-A1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-[5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL] -1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LIMITED (IN) | 2010-10-07 | — | — | WO | claimed |
| CN-115184485-A | Ezetimibe prodrug impurity detection method | 南京优科生物医药股份有限公司 | 2022-10-14 | — | — | CN | disclosed |
| EP-2417183-B1 | CURABLE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2013-01-16 | — | — | EP | disclosed |
| EP-2414339-B1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-[5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LTD (IN) | 2013-01-16 | — | — | EP | disclosed |
| EP-2414339-A1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-Ý5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL¨-1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | Lupin Ltd. (IN) | 2012-02-08 | — | — | EP | disclosed |
| EP-2414339-A1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-Ý5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL¨-1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | Lupin Ltd. (IN) | 2012-02-08 | — | — | EP | disclosed |
| US-20120028340-A1 | KINETIC RESOLUTION OF (4S) -- 4- PHENYL -- 3- [(5RS)-5-(4-FLUROPHENYL)-5- HYDROXYPENTANOYL] --1,3-OXAZOLIDIN-2-ONE TO THE (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LIMITED (IN) | 2012-02-02 | — | — | US | disclosed |
| US-20120028340-A1 | KINETIC RESOLUTION OF (4S) -- 4- PHENYL -- 3- [(5RS)-5-(4-FLUROPHENYL)-5- HYDROXYPENTANOYL] --1,3-OXAZOLIDIN-2-ONE TO THE (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LIMITED (IN) | 2012-02-02 | — | — | US | disclosed |
| WO-2010113184-A1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-[5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL] -1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LIMITED (IN) | 2010-10-07 | — | — | WO | disclosed |
| WO-2010113184-A1 | KINETIC RESOLUTION OF (4S)-4-PHENYL-3-[5(RS)-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL] -1,3 OXAZOLIDIN 2-ONE TO (5S) ISOMER VIA LIPASE CATALYZED ENANTIOSELECTIVE ESTERIFICATION OF THE (5R) ISOMER | LUPIN LIMITED (IN) | 2010-10-07 | — | — | WO | disclosed |
| US-7586015-B2 | Process for the preparation of 1,3,2-oxazaborolidine compounds | ZACH SYSTEM (FR) | 2009-09-08 | — | — | US | disclosed |
| US-7586015-B2 | Process for the preparation of 1,3,2-oxazaborolidine compounds | ZACH SYSTEM (FR) | 2009-09-08 | — | — | US | disclosed |
| US-20080139851-A1 | R2, R3, R4 and R5 are especially a hydrogen atom or an alkyl,wherein the following are reacted in two steps:a) a boric precursor compound with an acetal compound to give a boronate compound; and) the boronate compound with an amino alcohol compound | PPG-SIPSY (FR) | 2008-06-12 | — | — | US | disclosed |
| US-20080139851-A1 | R2, R3, R4 and R5 are especially a hydrogen atom or an alkyl,wherein the following are reacted in two steps:a) a boric precursor compound with an acetal compound to give a boronate compound; and) the boronate compound with an amino alcohol compound | PPG-SIPSY (FR) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139851-A1 | R2, R3, R4 and R5 are especially a hydrogen atom or an alkyl,wherein the following are reacted in two steps:a) a boric precursor compound with an acetal compound to give a boronate compound; and) the boronate compound with an amino alcohol compound | ADH1A, ADH1C, ADH5 | SLC18A3 2597/4885NAAA 2621/4885NPC1 4426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.